These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2547025)
1. Relationship between electrocortical activity and beta-adrenergic receptor function in the rat after chronic desimipramine treatment. Krijzer FN; Schipper J; Tulp MT; Koopman PA J Neural Transm Gen Sect; 1989; 78(1):73-87. PubMed ID: 2547025 [TBL] [Abstract][Full Text] [Related]
2. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment. Riva MA; Creese I Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051 [TBL] [Abstract][Full Text] [Related]
3. The significance of beta-adrenoceptor down regulation in the desipramine action in the forced swimming test. Kitada Y; Miyauchi T; Kosasa T; Satoh S Naunyn Schmiedebergs Arch Pharmacol; 1986 May; 333(1):31-5. PubMed ID: 2874504 [TBL] [Abstract][Full Text] [Related]
4. 5-Hydroxytryptamine2 and beta-adrenergic receptor regulation in rat brain following chronic treatment with desipramine and fluoxetine alone and in combination. Goodnough DB; Baker GB J Neurochem; 1994 Jun; 62(6):2262-8. PubMed ID: 8189233 [TBL] [Abstract][Full Text] [Related]
5. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment. Bergstrom DA; Kellar KJ J Pharmacol Exp Ther; 1979 May; 209(2):256-61. PubMed ID: 220405 [TBL] [Abstract][Full Text] [Related]
6. Effects of long-term desipramine administration on noradrenergic neurotransmission: electrophysiological studies in the rat brain. Lacroix D; Blier P; Curet O; de Montigny C J Pharmacol Exp Ther; 1991 Jun; 257(3):1081-90. PubMed ID: 1646320 [TBL] [Abstract][Full Text] [Related]
7. Effect of age on the rate of recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity. Greenberg LH; Brunswick DJ; Weiss B Brain Res; 1985 Feb; 328(1):81-8. PubMed ID: 2982468 [TBL] [Abstract][Full Text] [Related]
8. The influence of L-triiodothyronine (T3) on the effects of repeated administration of desipramine or electroconvulsive shock on alpha 2- and beta-adrenoceptor function in the brain of the rat: implications for the potentiation of antidepressant therapy by T3. Heal DJ; Bristow LJ; Elliott JM; Bloomfield JG; Catto LC; Atterwill CK Neuropharmacology; 1987 Aug; 26(8):1131-9. PubMed ID: 2821441 [TBL] [Abstract][Full Text] [Related]
9. Loss of rat cerebral cortical opiate receptors following chronic desimipramine treatment. Reisine T; Soubrie P Eur J Pharmacol; 1982 Jan; 77(1):39-44. PubMed ID: 6277652 [TBL] [Abstract][Full Text] [Related]
10. Presynaptic modulation of beta adrenergic receptors in rat cerebral cortex after treatment with antidepressants. Wolfe BB; Harden TK; Sporn JR; Molinoff PB J Pharmacol Exp Ther; 1978 Nov; 207(2):446-57. PubMed ID: 213556 [TBL] [Abstract][Full Text] [Related]
11. Agonist interactions with beta-adrenergic receptors following chronic administration of desipramine or the atypical antidepressants, iprindole and mianserin. Hancock AA; Marsh CL J Recept Res; 1985; 5(5-6):311-34. PubMed ID: 2868124 [TBL] [Abstract][Full Text] [Related]
12. Rapid decrease in rat brain beta adrenergic receptor binding during combined antidepressant alpha-2 antagonist treatment. Scott JA; Crews FT J Pharmacol Exp Ther; 1983 Mar; 224(3):640-6. PubMed ID: 6131122 [TBL] [Abstract][Full Text] [Related]
13. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour. Mudunkotuwa NT; Horton RW Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743 [TBL] [Abstract][Full Text] [Related]
14. [Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms]. Matsubara S Hokkaido Igaku Zasshi; 1987 Mar; 62(2):301-10. PubMed ID: 3038720 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of desmethylimipramine on the action of thyroxine on cardiac beta-receptors and myocardial phosphorylase. Hess ME; Reynolds KA; Frazer A; Viscusi D J Cardiovasc Pharmacol; 1980; 2(6):867-79. PubMed ID: 6160335 [TBL] [Abstract][Full Text] [Related]
17. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain. Ferris RM; Beaman OJ Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035 [TBL] [Abstract][Full Text] [Related]
18. Changes in the sensitivity of the central alpha- and beta-adrenergic systems during desmethylimipramine treatment as assessed by plasma growth hormone response in the baboon. McWilliam JR; Meldrum BS; Checkley SA Psychopharmacology (Berl); 1983; 80(3):263-6. PubMed ID: 6310666 [TBL] [Abstract][Full Text] [Related]
19. Effect of chronic desmethylimipramine or electroconvulsive shock on selected brain and platelet neurotransmitter recognition sites. Abel MS; Clody DE; Wennogle LP; Meyerson LR Biochem Pharmacol; 1985 Mar; 34(5):679-83. PubMed ID: 2983735 [TBL] [Abstract][Full Text] [Related]
20. Receptor dynamics: effect of repeated administration of desmethylimipramine on the noradrenergic systems in rat brain. Bürki HR; Rüdeberg C; Taimisto EL Postgrad Med J; 1981; 57 Suppl 1():71-6. PubMed ID: 6272253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]